Rob Brainin appointed CEO of Champions Oncology

The departure (and return) of Vinay Prasad

At the end of July, after just a few months as director of the Center for Biologics Evaluation and Research, Vinay Prasad resigned.

September 05, 2025

Vol.51 No.32

By Claire Marie Porter

Cancer Policy

FDA will speed up public release of Complete Response Letters

FDA is shortening its timeline for publicizing Complete Response Letters, pledging to make them available to the public “promptly” after sponsors receive notice.

John Byrd named director of UPMC Hillman Cancer Center

John C. Byrd, a physician scientist who specializes in hematologic malignancies, was appointed director of UPMC Hillman Cancer Center.

September 05, 2025

Vol.51 No.32

In Brief

Richard Schilsky leaves role as PI of ASCO’s TAPUR study

Richard L. Schilsky has left his role as inaugural principal investigator of the American Society of Clinical Oncology-led Targeted Agent and Profiling Utilization Registry study after a decade of leadership.

September 05, 2025

Vol.51 No.32

In Brief

Catheryn Yashar named president-elect of ASTRO

Catheryn Yashar, chief medical officer and breast and gynecologic cancer radiation oncologist at UC San Diego Health, was appointed president-elect of the American Society for Radiation Oncology.

September 05, 2025

Vol.51 No.32